The phrase "ascertain the differences in" is correct and usable in written English.
You can use it when you want to identify or determine the distinctions between two or more items, concepts, or situations.
Example: "In this study, we aim to ascertain the differences in consumer behavior between online and in-store shopping."
Alternatives: "determine the differences in" or "identify the differences in".
Listing the priorities is only the first step in a long agenda that must be carefully planned and executed and more work needs to be done in order to ascertain the differences in research priorities between high and low resource settings, or between different continents.
To ascertain the differences in smoking characteristics between a group of smokers with COPD and another group of healthy smokers, both of which were identified in a population-based epidemiologic study.
An experimental study has been undertaken to ascertain the differences in dynamic behaviour of cast-in and retrofitted shear connectors using a series of identical steel-concrete composite beams with various shear connection systems.
Further study is required to increase sample size to ascertain the differences in biomarkers and biochemical measurements between diabetic patients with CAD and controls.
The aim is to ascertain the differences (in terms of numbers, categories and timing) between negative and positive newspaper and scientific journal articles on SSRIs and suicidality.
The secondary objectives were to ascertain the differences in height, HSDS, HV, and HV standard deviation score from when the phase III study was finalized until adult height was reached.
We will compare these results to ascertain the difference in age groups on per contact transmission probabilities to and from particular age groups.
In this study, we attempt to ascertain the difference in the prognostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) between cardioembolic and noncardioembolic stroke subgroups.
Furthermore, in order to ascertain the difference in platelet change between old and young people, the enrolled sample was divided into young and old groups where the subjects ages were equal to or less than 75 years or more than 75 years, respectively.
With the aim of ascertaining the differences in the clinical and pathological characteristics and in the clinical course of these two groups of patients, we retrospectively evaluated and compared several clinico-pathologic and therapeutic issues and the outcome of patients with or without BRCA1-2 mutation.
